-
A Revolutionary Paradigm Shift in Big Pharma's Organisational Development: A paradigm is the conceptual framework upon which we build our world; it is built upon past experiences; if we are not willing to make shifts in our paradigms, we will remain stagnate in our growth; a paradigm shift is a change from one way of thinking to another; it is something that does not happen like self generation it is driven by change. read more
-
Taxing “Globesity” To Save Our Children: Will “Fat taxes” affect consumption, and eventually obesity? The impact of imposing taxes on the consumption of certain foods depends on the responsiveness of consumers to price changes, i.e. price elasticity. It is difficult to predict how consumers will react to price changes caused by taxation. read more
-
Big Pharma Cannot Afford to be Lost in Translation: Since more and more clinical research and drug manufacturing are being done in multiple countries and in multiple languages, quality language services can help bring a drug to market faster, and can help streamline the clinical trial process. Translation may be required at many stages, including clinical research, regulatory submission and review, production and marketing. read more
-
Personalized Medicine –A Game with More Than One Nash Equilibrium: PM is no longer about the pharma industry alone – the players/stakeholders go far beyond the pharmaceutical and biotechnology industries, presenting a new challenge in assembling diverse technologies and partners working together. Success in this space will require new approaches, new relationships, and new ways of thinking. read more
-
Sustain Your ELN – Before You Start Your ELN: Change management can be found as a bullet under “critical success factors” in many Electronic Lab Notebook project charters. Touted as crucial in determining the success of an ELN, many agree in principle that change management is needed, but don’t know how to go about making it effective, tangible, and measurable. read more
-
The Art of Measuring the ROI of ELNs - Keep it Real: Typical corporate business cases are created to demonstrate strategic alignment, define scope, identify risks, target resource requirements, obtain funds, and show the financial and operational benefits after the project has gone live, i.e. ROI. It’s this last set of measures that often remain elusive for ELNs, but are critical for project justification. read more
-
Being An Instrument of Change: Ask your colleague, “How can I make it easier for you when transferring over these products?” By doing this you are making the job easier for you and for them. How? read more
-
Whose Lab Kung Fu is Best?: In the movies no single person ever had the best Kung-Fu right from the start of the film. There were strikes on both sides and you saw that they quickly learned the strengths and weaknesses about themselves and their opponent. read more
-
Top 5 things You Need to Know about Inventory: Inventory is one of the primary wastes in lean thinking and is also the hardest for people to change their mindset about. I’ve compiled my list of the top 5 items you need to know in order to understand the downfall of having Inventory laying around. read more
-
Today’s Countermeasure is Tomorrow’s Standard: Areas of rapid growth and change cycle their “standard” processes quickly. Those that do manufacturing are much slower at developing countermeasures because of the checks and balances that need to be taken into consideration during implementation. read more
Events of Interest
-
Global Pharmaceutical Distribution 2012
Venue to be Confirmed, Amsterdam, The Netherlands
September 18- 19, 2012 -
Cool Chain Logistics 2013
Congress Center Basel, Basel, Switzerland
January 28- 30, 2013 -
Information Governance & eDiscovery for Pharma, Biotech and Medical Devices
London, UK
June 26- 28, 2012 -
Cold Chain Global Forum 2012
Chicago, IL
September 24- 28, 2012
Top Rated
Most Read
-
Career Spotlight: Pharma Regulatory Affairs
Pharma regulatory affairs | pharma regulatory affairs jobs | pharma regulatory affairs jobs in Mumbai
-
5 Challenges that Continue to Plague the $2 Billion Pharmacovigilance Sector
pharmacovigilance | pharmacovigilance Asia | Asia Pacific region
-
Survey: Benchmarking Your Pharmaceutical Contract Manufacturing Strategies
pharmaceutical contract manufacturing | pharma contract manufacturing survey | benckmarking contract manufacturing








Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!